Changing of the guard: Health marketing agencies Syneos Health and Evoke Kyne promote new female chiefs

Beth Snyder Bulik

Senior Editor

Two leading pharma and health marketing communications agencies tapped new women heads this week, both with backgrounds in Big Pharma.

Syneos Health promoted Michelle Keefe to CEO, while Evoke Kyne elevated Maureen Byrne to president. Keefe takes over for Alistair Macdonald, who is retiring after 20 years at Syneos, while Byrne takes the reins from David Kyne, who is moving into a new group president role in the parent Evoke.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Changing of the guard: Health marketing agencies Syneos Health and Evoke Kyne promote new female chiefs

Beth Snyder Bulik

Senior Editor

Unlock this article instantly by becoming a free subscriber.

AbbVie makes second deal in a week, betting $8.7B in cash on CNS biotech Cerevel

Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint

Aviv Regev leads Genentech's next revolution with AI

FDA approves Novartis drug for rare blood disorder

FDA sends letter to Novartis over Kymriah manufacturing safety concerns

Early prediction of outcomes in DLBCL clinical trials through MRD testing

Chang­ing of the guard: Health mar­ket­ing agen­cies Sy­neos Health and Evoke Kyne pro­mote new fe­male chiefs

Beth Snyder Bulik

Senior Editor

Unlock this article instantly by becoming a free subscriber.

Ab­b­Vie makes sec­ond deal in a week, bet­ting $8.7B in cash on CNS biotech Cerev­el

Pfiz­er plans to pull out of BIO, fol­low­ing moves by oth­er large drug­mak­ers to re­duce lob­by­ing foot­print

Aviv Regev leads Genen­tech's next rev­o­lu­tion with AI

FDA ap­proves No­var­tis drug for rare blood dis­or­der

FDA sends let­ter to No­var­tis over Kym­ri­ah man­u­fac­tur­ing safe­ty con­cerns

Ear­ly pre­dic­tion of out­comes in DL­B­CL clin­i­cal tri­als through MRD test­ing

Changing of the guard: Health marketing agencies Syneos Health and Evoke Kyne promote new female chiefs

AbbVie makes second deal in a week, betting $8.7B in cash on CNS biotech Cerevel

Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint

Aviv Regev leads Genentech's next revolution with AI

FDA approves Novartis drug for rare blood disorder

FDA sends letter to Novartis over Kymriah manufacturing safety concerns

Early prediction of outcomes in DLBCL clinical trials through MRD testing